Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dentstal Corporation LLC (შპს კორპორაცია დენტსტალი) imports and sells stomatological medicines and dental clinic equipment. That is the whole of what its own activity note to the FY2023 annual report describes: the note names no clinic, no treatment and no patient-facing service. It was previously classified as a dental clinic, which the note does not support. The filed P&L agrees with the note rather than the old label — gross margin is 47.8% on ₾3.7m of FY2022 revenue and 37.2% on ₾3.8m in FY2023, which is where device distributors sit in this database; dental clinics here run above 70% because their cost of sales is materials against chargeable labour. EBITDA fell from ₾1.42m to ₾0.43m between the two years while revenue was flat, so the gross margin gave way rather than the volume. Total assets are ₾6.6m against ₾3.8m of revenue. Its latest filing is FY2023, so it carries no FY2024 figures and must not be read as a zero in any FY2024 aggregate.
| Line item | 2022 | 2023 | CAGR |
|---|---|---|---|
| Total Revenue | 3,688 | 3,824 | +3.7% |
| Total COGS | 1,926 | 2,403 | +24.7% |
| Gross Profit | 1,762 | 1,421 | -19.4% |
| Gross Margin | 47.8% | 37.2% | |
| 341 | 988 | +189.9% | |
| EBITDA | 1,421 | 433 | -69.6% |
| EBITDA Margin | 38.5% | 11.3% | |
| Total D&A | 42 | 43 | +2.4% |
| EBIT / Operating Income | 1,379 | 389 | -71.8% |
| Total Interest Expense | 66 | 61 | -7.1% |
| Profit Before Tax | 1,313 | 328 | -75.0% |
| Total Income Tax | 4 | 0 | |
| Net Profit / (Loss) | 1,309 | 328 | -75.0% |
| Net Margin | 35.5% | 8.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →